RELB and glioblastoma: In GBM, chitinase 3-like 1 (Chi3l1) serves as a crucial marker for identifying the mesenchymal subtype and is linked to increased expression within oncogenic pathways, including NF-κB RelB and STAT-3/RTVP-1 signaling.